SOPHIA Trial in HER+ Metastatic Breast Cancer

SOPHIA Trial in HER+ Metastatic Breast Cancer

User Photo
obr

1 year
139 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Debu Tripathy, MD, Professor and Chair, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center explains the results of the SOPHIA trial, a phase III study of chemotherapy plus margetuximab or trastuzumab in HER+ metastatic breast cancer.
Up Next Autoplay